REG - GlaxoSmithKline PLC - Change of name to GSK plc

GSKAnnouncement

16/05/2022 14:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220516:nRSP6484La&default-theme=true

RNS Number : 6484L  GlaxoSmithKline PLC  16 May 2022

GSK plc

(the 'Company')

Change of name to GSK plc

The Company today confirms its name has changed from GlaxoSmithKline plc to
GSK plc.

The Company announced the decision to change its name to GSK plc on 27 April
2022 together with its first quarter 2022 results. This change has now taken
effect.

The London Stock Exchange and the New York Stock Exchange will reflect the
change of name in due course.

Shareholders should note that their shareholdings will be unaffected by the
change of name. Existing share certificates should be retained as they will
remain valid for all purposes and no new share certificates will be issued.

The ISINs, SEDOLs, CUSIPs and ticker symbols of the Company's ordinary shares
and ADS remain unchanged. The Company's Legal Entity Identifier (LEI) remains
5493000HZTVUYLO1D793.

V A Whyte

Company Secretary

16 May 2022

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  CANFLFVFEVIRLIF